RECOMMENDED LABORATORY SCREENING CORRESPONDING TEST CODE RECOMMENDED LABORATORY SCREENING OB Panel (can be ordered as a panel or individually)a CORRESPONDING QUEST TEST Obstetric Panel RECOMMENDED LABORATORY SCREENING OB Panel Individual components CORRESPONDING QUEST TEST CBC (includes Differential and Platelets) CORRESPONDING QUEST TEST Antibody Screen, RBC with Reflex to Identification, Titer, and Antigen Typingb CORRESPONDING QUEST TEST ABO Group and Rh Type CORRESPONDING QUEST TEST RPR (Diagnosis) with Reflex to Titer and Confirmatory Testingb (nontreponemal screening for syphilis) CORRESPONDING QUEST TEST Hepatitis B Surface Antigen with Reflex Confirmationb CORRESPONDING QUEST TEST Rubella Immune Status RECOMMENDED LABORATORY SCREENING Obstetric Panel with Fourth Generation HIV Individual components CORRESPONDING QUEST TEST This alternative panel is available and may be ordered to simultaneously screen for HIV infection, in addition to the tests above RECOMMENDED LABORATORY SCREENING Additional OB Panel component
CORRESPONDING QUEST TEST HIV-1/2 Antigen and Antibodies, Fourth Generation, with Reflexesb Additional informative 1st trimester tests RECOMMENDED LABORATORY SCREENING Cervical cytology screening, if indicateda CORRESPONDING QUEST TEST Image-Guided Pap with Age-Based Screening Protocolsa CORRESPONDING QUEST TEST Image-Guided Pap with Age-Based Screening with CT/NGa CORRESPONDING QUEST TEST Image-Guided Pap with Age-Based Screening with CT/NG, Trichomonasa CORRESPONDING QUEST TEST Pap alonea RECOMMENDED LABORATORY SCREENING Urinalysis CORRESPONDING QUEST TEST Urinalysis with Reflex to Microscopic CORRESPONDING QUEST TEST Urinalysis, Macroscopic RECOMMENDED LABORATORY SCREENING Zika Testing CORRESPONDING QUEST TEST Zika Virus RNA, Qualitative, Real-Time RT-PCR CORRESPONDING QUEST TEST Zika Virus RNA, Qualitative, Real-Time RT-PCR Panel, Serum/Urine CORRESPONDING QUEST TEST Zika Virus RNA, Qualitative Real-Time, RT-PCR, Serum/Urine and IgM Panel Although rates of Zika virus infection have decreased in the United States, obstetrician–gynecologists and other healthcare providers should continue to assess their patients for potential exposure based on travel or sexual history and test symptomatic patients with possible exposure and pregnant women with ongoing exposure regardless of symptoms in accordance with the Centers for Disease Control and Prevention recommendations. One or both of the following screens for fetal aneuploidy should be offered during the 1st trimester RECOMMENDED LABORATORY SCREENING Maternal Serum Screen (Part 1) CORRESPONDING QUEST TEST First Trimester Screen, hCG The screen includes PAPP-A (Pregnancy-associated Plasma Protein-A), hCG, Nuchal Translucency (NT) test; and risk assessments for trisomy 21 and trisomy 18 CORRESPONDING QUEST TEST Stepwise, Part 1 The screen includes PAPP-A (Pregnancy-associated Plasma Protein-A), hCG, Nuchal Translucency (NT); and risk assessments for trisomy 21 and trisomy 18 CORRESPONDING QUEST TEST Serum Integrated Screen, Part 1 PAPP-A (Pregnancy-associated Plasma Protein-A) CORRESPONDING QUEST TEST Sequential Integrated Screen, Part 1 This screen includes PAPP-A (Pregnancy-associated Plasma Protein-A), hCG, Nuchal Translucency (NT), Down syndrome, and trisomy 18 risk and interpretation CORRESPONDING QUEST TEST Integrated Screen, Part 1 This screen includes PAPP-A (Pregnancy-associated Plasma Protein-A) and Nuchal Translucency (NT) RECOMMENDED LABORATORY SCREENING Noninvasive prenatal screening CORRESPONDING QUEST TEST QNatal® Advanced Informative infectious disease 1st trimester tests RECOMMENDED LABORATORY SCREENING Tuberculosis (TB), if indicatedc CORRESPONDING QUEST TEST QuantiFERON®-TB Gold Plus, 1 Tube CORRESPONDING QUEST TEST QuantiFERON®-TB Gold Plus, 4 Tubes, Draw Site Incubated CORRESPONDING QUEST TEST T-SPOT®.TB RECOMMENDED LABORATORY SCREENING Chlamydiad CORRESPONDING QUEST TEST Chlamydia trachomatis RNA, TMA, Urogenital RECOMMENDED LABORATORY SCREENING Gonorrhea, if indicatedd CORRESPONDING QUEST TEST Neisseria gonorrhoeae RNA, TMA, Urogenital RECOMMENDED LABORATORY SCREENING Chlamydia and gonorrhea CORRESPONDING QUEST TEST Chlamydia/Neisseria gonorrhoeae RECOMMENDED LABORATORY SCREENING HIV testing CORRESPONDING QUEST TEST HIV-1/2 Antigen and Antibodies, Fourth Generation, with Reflexesb RECOMMENDED LABORATORY SCREENING Hepatitis C testing CORRESPONDING QUEST TEST Hepatitis C Antibody with Reflex to HCV, RNA, Quantitative, Real-Time PCRb CORRESPONDING QUEST TEST Hepatitis C Antibody with Reflex to HCV RNA,PCR w/Reflex to Genotype, LiPA® Hereditary cancer risk assessmentACOG recommends that OB/GYNs perform a hereditary cancer risk assessment to help identify patients who may be at risk of developing certain types of cancer.1 For patients with a family or personal history of breast or ovarian cancer, Ashkenazi Jewish ancestry, or other potential heritable conditions, genetic testing can provide valuable information to help inform the best treatment decisions. Our hereditary cancer testing is performed on a next-generation sequencing platform in conjunction with our proprietary software to allow for the most accurate identification of disease. Learn more CDC screening guidelines for chlamydia and gonorrhea during pregnancyAll pregnant women aged <25 years, or older women at increased risk2 for infection, should be screened during their first prenatal visits.*
*Patients with increased risk are women with a history of multiple sexual partners or a sexual partner with multiple contacts, sexual contact with individuals with culture-proven STDs, a history of repeated episodes of STDs, or attendance at clinics for STDs. QNatal® AdvancedQNatal® Advanced is a low-risk, noninvasive cell-free DNA (cfDNA) prenatal screen that can detect the most common fetal aneuploidies, including Down syndrome. Learn more RECOMMENDED LABORATORY SCREENING CORRESPONDING TEST CODE RECOMMENDED LABORATORY SCREENING CBC CORRESPONDING QUEST TEST CBC (includes Differential and Platelets) This screen includes WBC, RBC, Hemoglobin, Hematocrit, MCV, MCH, MCHC, RDW, Platelet Count, MPV and Differential (absolute and percent neutrophils, lymphocytes, monocytes, eosinophils, and basophils) CORRESPONDING QUEST TEST CBC (H/H, RBC, Indices, WBC, Plt) This screen includes WBC, RBC, Hemoglobin, Hematocrit, MCV, MCH, MCHC, RDW, Platelet Count RECOMMENDED LABORATORY SCREENING Gestational diabetes screening CORRESPONDING QUEST TEST Glucose Gestational Screen (50g), 135 Cutoff (ACOG supported 1st step of 2-step GDM evaluation) CORRESPONDING QUEST TEST Glucose Gestational Screen (50g), 140 Cutoff (ACOG supported 1st step of 2-step GDM evaluation) CORRESPONDING QUEST TEST Glucose Tolerance Test, Gestational, 4 specimens (100g) (ACOG supported 2nd step of 2-step GCM valuation) One or more of the following should be offered as appropriate in the 2nd trimester RECOMMENDED LABORATORY SCREENING Quad Screene CORRESPONDING QUEST TEST Quad Screen RECOMMENDED LABORATORY SCREENING Maternal Serum Screen (Part 2) CORRESPONDING QUEST TEST Serum Integrated Screen, Part 2 This screen includes AFP, hCG, uE3, and DIA RECOMMENDED LABORATORY SCREENING Maternal Serum Alpha-Fetoprotein CORRESPONDING QUEST TEST Maternal Serum AFP RECOMMENDED LABORATORY SCREENING Diagnostic Chromosomal Analysis via amniocentesis or chorionic villus sampling, if indicatede CORRESPONDING QUEST TEST Chromosome Analysis, Chorionic Villus Sample CORRESPONDING QUEST TEST Chromosome Analysis, Amniotic Fluidb Quanum® Interactive Insights™Our enhanced reporting tool can help you have more meaningful conversations with patients about their lab test results. Learn more. Obesity in pregnancyMore than half of pregnant women in the United States are overweight or obese,3 putting them at greater risk of pregnancy complications, such as gestational diabetes, preeclampsia, cesarean delivery, and giving birth to an infant with congenital anomalies. ACOG recommendations for counseling obese patients include:
RECOMMENDED LABORATORY SCREENING CORRESPONDING TEST CODE RECOMMENDED LABORATORY SCREENING CBC CORRESPONDING QUEST TESTS CBC (includes Differential and Platelets) CORRESPONDING QUEST TESTS CBC (H/H, RBC, Indices, WBC, Plt) RECOMMENDED LABORATORY SCREENING D (Rh) antibody screen CORRESPONDING QUEST TEST Antibody Screen, RBC with Reflex to Identification, Titer, and Antigen Typinge RECOMMENDED LABORATORY SCREENING Group B streptococcal disease CORRESPONDING QUEST TESTS Streptococcus Group B Culture CORRESPONDING QUEST TESTS Streptococcus Group B with Susceptibility Culture CORRESPONDING QUEST TESTS Streptococcus Group B DNA, CORRESPONDING QUEST TESTS Streptococcus Group B DNA, PCR with Broth Enrichment and Reflex to Susceptibilitye RECOMMENDED LABORATORY SCREENING Chlamydia (if patient tested positive or is high risk due to age or lifestyle) CORRESPONDING QUEST TEST Chlamydia trachomatis RNA, TMA, Urogenital RECOMMENDED LABORATORY SCREENING Gonorrhea (if patient tested positive or high risk due to age or lifestyle) CORRESPONDING QUEST TEST Neisseria gonorrhoeae RNA, TMA, Urogenital RECOMMENDED LABORATORY SCREENING Chlamydia and gonorrhea (if patient tested positive or high risk due to age or lifestyle) CORRESPONDING QUEST TEST Chlamydia/Neisseria gonorrhoeae RECOMMENDED LABORATORY SCREENING RPR (if patient tested positive or high risk due to age or lifestyle) CORRESPONDING QUEST TEST RPR (Diagnosis) with Reflex to Titer and Confirmatory Testinge RECOMMENDED LABORATORY SCREENING HIV testing (if patient is high risk due to lifestyle) CORRESPONDING QUEST TEST HIV-1/2 Antigen and Antibodies, Fourth Generation, with Reflexesb Retesting for chlamydia and gonorrhea is important for those at increased riskThose aged <25 years and those at increased risk* for chlamydia or gonococcal infection should be retested during their 3rd trimester.2 *Patients are women with a history of multiple sexual partners or a sexual partner with multiple contacts, sexual contact with individuals with culture-proven STDs, a history of repeated episodes of STDs, or attendance at clinics for STDs. a The age-based offerings are based on ACOG recommendations and include image-guided Pap tests. Non-imaged Paps as well as conventional Paps are also available at Quest Diagnostics. Test codes may vary by location. Please contact your local laboratory or go to QuestDiagnostics.com/TestCenter for more information. b Reflex testing may be performed at an additional charge. c Risk factors include known HIV infection; close contact with individuals known or suspected to have TB; medical risk factors such as diabetes, lupus, cancer, alcoholism, and drug addiction; birth in or emigration from countries with high prevalence; being medically underserved; homelessness; living or working in long-term care facilities, such as correctional institutions, mental health institutions, and nursing homes. d If positive, test-of-cure should be performed within 3-4 weeks post-treatment. e If Antibody Screen is positive, Antibody Identification, Titer, and Antigen Typing will be performed at an additional charge. If RPR screen is reactive, RPR Titer and FTA Confirmatory testing will be performed at an additional charge. When only a single test, Hepatitis B Surface Antigen, is ordered to diagnose Hepatitis B in a pregnant woman, additional tests such as liver enzymes should be ordered to confirm the diagnosis. Test codes may vary by location. Please contact your local laboratory for more information. |
Quest diagnostics pregnancy blood test results time
Related Posts
Copyright © 2024 berikutyang Inc.
